MAQS Advokatbyra acted as legal adviser to PowerCell in connection with the share issue. PowerCell Sweden AB (publ) carried out a directed issue of 5.75 million...
You must be a Standard 1 Year member to access this content.
MAQS advised Neudi & Co on the deal. Neudi & Co secured an agreement for the sale of Wint to the Norwegian private equity-firm Norvestor. Norvestor...
You must be a Standard 1 Year member to access this content.
MAQS legal advised Fluicell on the offering. Fluicell AB (publ) has carried out a rights issue of units. The right issue was fully subscribed, and the...
You must be a Standard 1 Year member to access this content.
MAQS acted as legal advisor to PowerCell. PowerCell completed a listing change from Nasdaq First North Growth Market to the main list of Nasdaq Stockholm. PowerCell...
You must be a Standard 1 Year member to access this content.
MAQS advised Energy Save on the deal. ES Energy Save Holding AB (Energy Save) has been approved for listing on Nasdaq First North Growth Market. Energy...
You must be a Standard 1 Year member to access this content.
North Point Securities acted as financial advisor and MAQS Advokatbyrå was legal advisor to Luxbright in in connection with the rights issue. Luxbright AB (publ) has...
You must be a Standard 1 Year member to access this content.
MAQS Advokatbyrå assisted Gapwaves on the matter. Gapwaves (STO:GAPW-B) has entered into an agreement to acquire 30 percent of the radar sensor company Sensrad. Through the...
You must be a Standard 1 Year member to access this content.
MAQS advised Energy Save on the deal. ES Energy Save Holding AB (publ) (”Energy Save”) has carried out a directed right issue that will provide the...
You must be a Standard 1 Year member to access this content.
Maqs advised Luxbright on the deal LUXBRIGHT AB (publ) has completed a fully subscribed rights issue, which will provide Luxbright with issue proceeds amounting to approximately...
You must be a Standard 1 Year member to access this content.
MAQS Advokatbyrå advised QuiaPEG Pharmaceuticals on the deal. QuiaPEG Pharmaceuticals Holding AB (publ) has carried out a fully guaranteed issue of units consisting of shares, warrants...
You must be a Standard 1 Year member to access this content.
MAQS has advised QuiaPEG Pharmaceuticals Holding AB on the transaction. QuiaPEG Pharmaceuticals Holding AB (publ) announced two directed issue of shares and warrants to several Swedish and...
You must be a Standard 1 Year member to access this content.
MAQS has advised Zesec of Sweden on the deal. In connection with the listing, Zesec has carried out a rights issue to the public of 2,150,000...
You must be a Standard 1 Year member to access this content.
